Kristin Anthony, President, and Founder
Stephen E. Pazian Sr., Vice President
Stephen Pazian owns Nature Coast Ventures, Inc. (NCV) which is working with SH Seafood LLC to provide for this frozen seafood distributor’s capital needs as well as the marketing of new products. In late 2008, NCV launched a start-up business, Para Membranes of North America LLC, developing large business accounts as the exclusive North American Distributor for a South Korean filtration membrane manufacturer. Prior to that, Mr. Pazian served as Chairman, President and Chief Executive Officer of PRISMEDICAL Corporation, a private equity owned water filtration, medical device manufacturing, government research and development turnaround/restart. Mr. Pazian has led national companies in several industries and has extensive industry consolidation, turnaround, restart, and startup experience, He has developed organizations with no more than a concept to revenue generation, built businesses to over $300 million in annual revenues & 4000 employees and led industries in profitability. Mr. Pazian served on three VC/PE funded company boards and on the division boards of BellSouth including BellSouth Cellular (now AT&T Wireless) and BellSouth MobileComm.
Stan Anthony, Treasurer
Stan Anthony is the Director of Product and Supplier quality in the Project Management Office for Vertiv Corporation. Stan has more than 10 years of project management experience holding management roles in production engineering with Intuitive Research, and as the NAFTA Director of Project Management for Continental Automotive. International and stateside achievements include: Successfully launching six new $100+ million dollar products as a project manager: on time, below budget, high quality, with great customer acceptance. Projects took place during a major change in ownership and culture between Chrysler, Siemens VDO, and Continental. Additional successes include reducing R&D budget by $1.35 million in fiscal 2008 to match global budget decrease, yet achieved all development milestones for the year, and maintained good customer relationships. Stan also held an international assignment at corporate headquarters managing Continental’s diesel electronics business in Germany and the Czech Republic with $20 million sales and a $12 million R&D budget. Stan also managed a multi-million dollar project yielding over $500 million in lifetime gross revenue, which was key to the manufacturing plant’s success.
Dr. Michael McFadden, Medical Advisory Committee
Dr. Mcfadden attended Auburn University and graduated with a degree in electrical engineering in 1989, and then took a job as an electronic warfare test engineer with Lockheed Martin Aeronautics Division in Fort Worth, Texas. During my career there I performed aircraft testing and design tasks on the F-16 and F-22 fighter programs. Dr. Mcfadden left Lockheed Martin in 1994 to pursue a career in medicine. He enrolled in medical school at Texas A&M College of Medicine. Dr. Mcfadden graduated Summa Cum Laude in 1999, and then entered residency at Shands Hospital at The University of Florida where he completed an internship in General Surgery and residency in Otolaryngology. Upon completion of my residency in 2004, Dr. Mcfadden joined North Alabama ENT Associates in Huntsville, Alabama, where he still practices today. During my time at Huntsville Hospital, I have served as Vice Chairman and Chairman of the Department of Surgery and I am currently Secretary of the Medical Staff.
Thomas “Tom” Houser initially served a career as an Army Aviator and later as a staff officer. Early in his career, he completed two combat tours in Vietnam, where he flew helicopters and commanded two aviation units. On the Army Staff, he was the Executive Officer to the Director of Force Development in DCSOPS. Later, he served in the Strategic Defense Initiative in its initial stages and was responsible for all ground-based kinetic energy weapon systems.
Tom became the President and COO of MEVATEC Corporation in 1989, which was acquired by BAE Systems in 2003. During this 14-year span, MEVATEC grew from $50,000 in sales to over $120 million and won numerous awards for excellence. At BAE Systems, he continued to run daily operations for a business unit with annual sales of $250M. He also supported strategic planning and mergers and acquisitions at BAE and later became a Managing Director of ISI Partners, an investment banking firm, specializing in mergers and acquisitions of companies in the government services sector.
Mr. Houser joined S3, Inc. as President in April 2010, responsible for technical program execution and tactical corporate growth. With S3’s 2014 formation of System Studies and Simulation International, a subsidiary of S3, Tom agreed to apply his experience to growing startup businesses to develop S3I.
He is currently the COO of Whitespace Innovations, a business growth mentoring firm specializing in developing effective metrics-based strategies and guiding clients through capture and proposal development for key opportunities.
Mr. Houser received a B.S. in Management and Economics from the University of Tampa and an M.S. in Electronic Warfare Systems Engineering from the Naval Postgraduate School, where he did research in the area of refractive effects on tactical electromagnetic systems. Mr. Houser is married to Jean and has four children, Scott, Allen, Wendy, and Mark. He is a Trustee of Samford University and serves on corporate and charitable boards.
Ashley Jones is a shareholder in the law firm of Wilmer & Lee, P.A. in Huntsville, Alabama. Mr. Jones earned an undergraduate degree in electrical engineering from the University of Alabama- Huntsville in 1990. He graduated from the University of Alabama School of Law in 1994. Mr. Jones has also obtained a Masters in Taxation from New York University School of Law. Mr. Jones has practiced law in Huntsville, Alabama for over twenty years. His practice focuses on the areas of business and corporate law, estate planning, contracts, probate, and taxation.
Saira Sultan has represented corporate, nonprofit, and government interests in the legislative and regulatory health policy arena for more than 20 years in Washington, D.C. She has had repeated success in designing business solutions by identifying and creating advocacy opportunities and translating them into strategic legislative and regulatory results. Saira brings a decade of experience working with market access, health outcomes, and commercial teams in pharmaceutical companies, including Pfizer and Sanofi. Saira is an experienced project management lead for large cross-functional efforts at Medtronic, Pfizer, Sanofi, and more.
Focusing on areas such as oncology, vaccines, and specialty products in sickle cell and arthritis, Saira has worked extensively with CMS, FDA, and Capitol Hill. Her insight and skill in working cross-functionally in a corporate environment, as well as with advocacy organizations and key trade associations serve her clients well. Saira’s leadership at the Association of Community Cancer Centers (ACCC) allowed her to build strong relationships with the oncology community and gain insights into the evolution of oncology care. She continues to work in close collaboration with many oncology organizations, identifying emerging trends that have led to repeated success in tackling coverage, coding and payment of marketed and pipeline Part B and D products. The Government Affairs and Policy team at ACCC, under Saira’s direction, raised significant revenue, improved the Association’s profile, as she became a sought-after speaker on oncology policy issues. Complementing her ten years in pharmaceuticals, Saira’s time at Medtronic gives her an in-depth understanding of the unique needs of the device industry. Representing Medtronic at a time when CMS was completely revamping device reimbursement in hospital outpatient departments, gave her the opportunity to work in close collaboration with CMS and key stakeholders. Saira built a successful coalition of varied stakeholders that ensured reimbursement for Class III devices reflecting their value to patients.
Additionally, Saira brings House and Senate experience, including work on the Ways and Means Committee, and roles as senior legislative counsel for Senator Mike DeWine (R-OH) and Chief Counsel to one of the Senate Healthcare Subcommittees. She handled all healthcare issues under the Senate HELP Committee’s jurisdiction, including extensive negotiations with FDA and industry on the Balanced Budget Act of 1997 and the first reauthorization of the Prescription Drug User Fee Act. She spearheaded passage of the first Better Pharmaceuticals for Children.
Saira holds a JD from the University of Virginia in Charlottesville, VA.
Brandy Smith currently serves as Vice President at Renasant Bank and has more than fifteen years experience in the banking and finance industry. Brandy is passionate about giving back to her community and currently, serves on the Board of Directors as President for Huntsville Free Dental Clinic, past President of Greengate School of Dyslexia and Board of Directors for The Huntsville Library Foundation. Brandy has also served as past Treasurer for the Huntsville Museum of Art –Art Krewe and is a member of the Museum Guild. Additionally, Smith serves on the Board of Directors of American Red Cross and was the 2017 100th year American Red Cross Gala Chairperson. Brandy is a past member of HudsonAlpha Connections Class and currently, serves on the HudsonAlpha Professional Advisor’s Council. Brandy is a member of River Tree Church, and together, she and her husband James are raising five children, Ashlyn, Emma Cate, Wyatt, Harrison, and Hudson.
Lori Ortega resides in Staten Island, NY and has been a teacher for 21 years, however, she feels that her most important and fulfilling job is raising her daughter Meghan. Both Lori and Meghan have a PTEN mutation. Lori and her husband Felix are raising their daughter as they manage work, home life, and all of the challenges that come with a PTEN diagnosis. Despite the adversity, Lori chooses life. She is a friend to all who know her and an extraordinary advocate in the PTEN community. Lori finds joy in sharing her families journey at www.beatingcowdens.com. Through this platform, she connects with patients offering them hope, and she is passionate about encouraging others as she teaches the PTEN community how to “Beat Cowdens.” We are thrilled to have Lori as a member of our PTEN Foundation team. Her altruistic compassion for others makes her an excellent PTEN advocate.
Bruce R. Korf, M.D., Ph.D.
Dr. Korf is the Chief Genomics Officer, UAB Medicine, Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor of Genetics, Co-Director of the UAB-HudsonAlpha Center for Genomic Medicine, and Associate Director for Rare Diseases, Hugh Kaul Personalized Medicine Institute. He is a medical geneticist, pediatrician, and child neurologist, certified by the American Board of Medical Genetics and Genomics (clinical genetics, clinical cytogenetics, clinical molecular genetics), American Board of Pediatrics, and American Board of Psychiatry and Neurology (child neurology). Dr. Korf is past president of the Association of Professors of Human and Medical Genetics, past president of the American College of Medical Genetics and Genomics, and current president of the ACMG Foundation for Genetic and Genomic Medicine. He has served on the Board of Scientific Counselors of the National Cancer Institute and the National Human Genome Research Institute at the NIH. His major research interests are molecular diagnosis of genetic disorders and the natural history, genetics, and treatment of neurofibromatosis. He serves as principal investigator of the Department of Defense funded Neurofibromatosis Clinical Trials Consortium, the Alabama Genomic Health Initiative, and the Southern All of Us Network. He is a co-author of Human Genetics and Genomics (medical student textbook, now in the fourth edition), Medical Genetics at a Glance (medical student textbook now in third edition), Emery and Rimoin’s Principles and Practice of Medical Genetics (now in the 6th edition), and Current Protocols in Human Genetics. He is also the incoming editor-in-chief of the American Journal of Human Genetics.